Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Influenza

Free Subscription 02.03.2026 3 Arch Virol 1 Biochem Biophys Res Commun 1 BMC Pediatr 1 BMJ 1 Drug Saf 1 Epidemiol Infect 1 J Gen Virol 3 J Immunol 1 J Infect 7 PLoS One 1 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Arch Virol

1. KOBAYASHI D, Hiono T, Adachi R, Igarashi M, et al
   Length and density of alpha2-3 sialyllactose-containing chains on glycopolymers determine receptor binding of avian influenza viruses.
   Arch Virol. 2026;171:100.
   PubMed        
   
   
2. PARK SH, Lee SH, Seo YR, Kim DJ, et al
   Evolution and spread of H8Nx avian influenza viruses from wild birds in East Asia, 2019-2024.
   Arch Virol. 2026;171:95.
   PubMed         Abstract available
   
   
3. NAVEED A
   The bovine mammary gland as a crucible for zoonotic influenza virus emergence: Receptor-mediated adaptation of HPAI H5N1 clade 2.3.4.4b.
   Arch Virol. 2026;171:89.
   PubMed        
   
   

   
   Biochem Biophys Res Commun

4. SINGH VA, Nehul S, Saha A, Singh V, et al
   Bioengineered chimeric VLPs targeting chikungunya virus and SARS-CoV-2 show high immunogenicity in mice.
   Biochem Biophys Res Commun. 2026;805:153346.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

5. KARAKURT LT, Bozkurt HB, Uslu G, Bal F, et al
   Attitudes and behaviors of adolescents with asthma and their parents toward influenza and COVID-19 vaccination: barriers and facilitators of uptake.
   BMC Pediatr. 2026 Feb 26. doi: 10.1186/s12887-026-06575.
   PubMed        
   
   

   
   BMJ

6. VANDVIK PO, Agarwal A, Rylance J, Agoritsas T, et al
   Summary of WHO clinical practice guidelines for influenza.
   BMJ. 2026;392:e087397.
   PubMed         Abstract available
   
   

   
   Drug Saf

7. MORGAN HJ, Bloomfield L, Clothier HJ, Ngeh S, et al
   Statistical Methods for Multi-jurisdictional Australian Vaccine Safety Investigations of Rare Adverse Events.
   Drug Saf. 2026;49:353-365.
   PubMed         Abstract available
   
   

   
   Epidemiol Infect

8. UNNIKRISHANAN R, Zhao Y, Burgess CP, Markey PG, et al
   Measuring the excess mortality during the COVID-19 pandemic in the Northern Territory, Australia.
   Epidemiol Infect. 2026;154:e26.
   PubMed         Abstract available
   
   

   
   J Gen Virol

9. FARRELL ML, McGrath G, Cuartero LG, Barry G, et al
   Avian influenza in Ireland: a spatiotemporal, subtype and host-based analysis (1983-2024).
   J Gen Virol. 2026;107:002218.
   PubMed         Abstract available
   
   

   
   J Immunol

10. APPS R, Polanco JJ, Lowman KE, Wang L, et al
    Leveraging optimized oligonucleotide-tagged antigen assemblies and single-cell sequencing for multiplexed proteogenomic profiling of human B cell reactivities.
    J Immunol. 2026;215:vkaf301.
    PubMed         Abstract available
    
    
11. LOPEZ ZAPANA PA, Shook LL, Joughin BA, Jasset OJ, et al
    Maternal proteome profiling reveals dynamic gestational age-specific responses to de novo vaccination.
    J Immunol. 2025 Dec 12:vkaf298. doi: 10.1093.
    PubMed         Abstract available
    
    
12. CONDE L, Oliveira DL, Maciel G, Castro F, et al
    Highly efficient and low-cost single-cell culture platform for unbiased analysis of human memory B cell repertoire and antibody discovery.
    J Immunol. 2026;215:vkaf305.
    PubMed         Abstract available
    
    

    
    J Infect

13. ORDONEZ-MENA JM, Radin JM, Hoang U, Araujo AB, et al
    Epidemiology of virologically confirmed RSV, influenza and COVID-19 in adults in England, 2023-2024: Primary Care Observational Study of Acute Respiratory Infection (ObservatARI).
    J Infect. 2026 Feb 21:106714. doi: 10.1016/j.jinf.2026.106714.
    PubMed         Abstract available
    
    

    
    PLoS One

14. N'DIAYE A, Garrett C, Wilcox S, Olatosi B, et al
    Challenges, stressors, and resilience resources experienced by older black women in Rural South Carolina throughout the COVID-19 pandemic.
    PLoS One. 2026;21:e0342512.
    PubMed         Abstract available
    
    
15. SEIBERT FS, Kurucay M, Wiemers L, Stervbo U, et al
    Association of G-Protein-Coupled Receptors autoantibodies with vasoregulation in Post-COVID.
    PLoS One. 2026;21:e0343264.
    PubMed         Abstract available
    
    
16. BAYARAA O, Ganbold C, Byambadorj B, Battulga Z, et al
    The synergistic interaction between ACE and TMPRSS2 polymorphisms increases the risk of severe COVID-19.
    PLoS One. 2026;21:e0343590.
    PubMed         Abstract available
    
    
17. KHEZRI R, Ebrahimi K, Askari S, Jahanfar S, et al
    Maternal and neonatal outcomes following SARS-CoV-2 infection in an unvaccinated pregnant cohort: A trimester-specific analysis.
    PLoS One. 2026;21:e0341647.
    PubMed         Abstract available
    
    
18. FINKELSTEIN A, Genut S, Golos A
    Experiences of women with disabilities during and after COVID-19: Needs, sources of support and implications for policy and practice.
    PLoS One. 2026;21:e0342900.
    PubMed         Abstract available
    
    
19. ELGNER M, Binnebose M, Grossmann J, Frank T, et al
    How to cope with Long COVID - A qualitative interview study on stressors and coping strategies of people affected by long-term consequences of COVID-19.
    PLoS One. 2026;21:e0343115.
    PubMed         Abstract available
    
    
20. PIN C, Taylor S, Ferreira C, Arnetorp S, et al
    A dynamic model of COVID-19 infection quantifies the impact of preventive interventions on the infection of severely immunocompromised subjects in the United Kingdom.
    PLoS One. 2026;21:e0341331.
    PubMed         Abstract available
    
    

    
    Vaccine

21. PEREDO R, Savard N, Separovic L, Zhan Y, et al
    Influenza vaccination status ascertainment and vaccine effectiveness estimation: Validity of self-report for current and prior season.
    Vaccine. 2026;77:128368.
    PubMed         Abstract available
    
    

    
    Virology

22. LOPEZ-LOPEZ N, Mejia-Torres M, Diaz-Caldera MA, Martinez-Castilla AM, et al
    Sequential infection with rhinovirus followed by Influenza Virus led to an increased antiviral response in A549 cells.
    Virology. 2026;618:110847.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum